Tevogen Bio Holdings Inc. Files Q1 2025 10-Q

Ticker: TVGNW · Form: 10-Q · Filed: May 14, 2025 · CIK: 1860871

Tevogen Bio Holdings Inc. 10-Q Filing Summary
FieldDetail
CompanyTevogen Bio Holdings Inc. (TVGNW)
Form Type10-Q
Filed DateMay 14, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, biotech, financials

Related Tickers: TVGN

TL;DR

Tevogen Bio (TVGN) filed its Q1 2025 10-Q. All systems go.

AI Summary

Tevogen Bio Holdings Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly Semper Paratus Acquisition Corp., is in the biological products sector and is incorporated in Delaware. Its business address is in Warren, NJ.

Why It Matters

This filing provides investors with an update on Tevogen Bio's financial performance and operational status for the first quarter of 2025.

Risk Assessment

Risk Level: medium — As a biotech company, Tevogen Bio Holdings Inc. faces inherent risks related to research, development, regulatory approval, and market adoption of its products.

Key Numbers

  • 20250331 — Reporting Period End Date (Indicates the end of the fiscal quarter covered by the report.)
  • 20250514 — Filing Date (The date the 10-Q was officially submitted to the SEC.)

Key Players & Entities

  • Tevogen Bio Holdings Inc. (company) — Filer of the 10-Q
  • Semper Paratus Acquisition Corp. (company) — Former name of Tevogen Bio Holdings Inc.
  • 20250331 (date) — End of the reporting period
  • 15 Independence Boulevard, Suite 410, Warren, NJ 07059 (location) — Business and mailing address
  • 646-807-8832 (phone_number) — Business phone number

FAQ

What is the primary business of Tevogen Bio Holdings Inc.?

Tevogen Bio Holdings Inc. is in the business of biological products, specifically excluding diagnostic substances, as indicated by its SIC code [2836].

When was Tevogen Bio Holdings Inc. formerly known as?

Tevogen Bio Holdings Inc. was formerly known as Semper Paratus Acquisition Corp., with a name change effective May 5, 2021.

What is the fiscal year end for Tevogen Bio Holdings Inc.?

The fiscal year end for Tevogen Bio Holdings Inc. is December 31.

What is the business address of Tevogen Bio Holdings Inc.?

The business address is 15 Independence Boulevard, Suite 410, Warren, NJ 07059.

What is the SEC file number for Tevogen Bio Holdings Inc.?

The SEC file number for Tevogen Bio Holdings Inc. is 001-41002.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on May 14, 2025 regarding Tevogen Bio Holdings Inc. (TVGNW).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.